MorphoSys AG
MPSYF · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $238,278 | $278,267 | $179,600 | $327,698 |
| % Growth | -14.4% | 54.9% | -45.2% | – |
| Cost of Goods Sold | $58,355 | $48,620 | $32,200 | $9,174 |
| Gross Profit | $179,923 | $229,647 | $147,400 | $318,524 |
| % Margin | 75.5% | 82.5% | 82.1% | 97.2% |
| R&D Expenses | $283,614 | $297,812 | $225,200 | $141,427 |
| G&A Expenses | $86,218 | $83,896 | $78,300 | $51,403 |
| SG&A Expenses | $92,538 | $90,225 | $199,800 | $159,146 |
| Sales & Mktg Exp. | $6,320 | $6,329 | $121,500 | $107,743 |
| Other Operating Expenses | $968 | $62,321 | $1,800 | $0 |
| Operating Expenses | $430,780 | $450,358 | $425,000 | $300,573 |
| Operating Income | -$252,476 | $162,262 | -$277,600 | $119,408 |
| % Margin | -106% | 58.3% | -154.6% | 36.4% |
| Other Income/Exp. Net | $61,554 | $238,232 | -$313,500 | $4,540 |
| Pre-Tax Income | -$190,922 | $17,521 | -$591,100 | $22,492 |
| Tax Expense | -$1,189 | $168,579 | -$76,600 | -$75,399 |
| Net Income | -$189,734 | -$151,058 | -$514,500 | $97,891 |
| % Margin | -79.6% | -54.3% | -286.5% | 29.9% |
| EPS | -5.53 | -4.42 | -15.4 | 3.01 |
| % Growth | -25.1% | 71.3% | -611.6% | – |
| EPS Diluted | -5.53 | -4.42 | -15.4 | 2.97 |
| Weighted Avg Shares Out | 34,310 | 34,156 | 33,401 | 32,948 |
| Weighted Avg Shares Out Dil | 34,313 | 34,156 | 33,401 | 33,168 |
| Supplemental Information | – | – | – | – |
| Interest Income | $18,316 | $4,618 | $96,600 | $92,047 |
| Interest Expense | $109,858 | $116,520 | $181,500 | $96,214 |
| Depreciation & Amortization | $14,208 | $10,412 | $10,090 | $8,316 |
| EBITDA | -$97,738 | $172,797 | -$331,124 | $127,738 |
| % Margin | -41% | 62.1% | -184.4% | 39% |